VRCI:LSE Verici Dx Plc

GBX 9.25 0.00 0
Icon

Verici Dx Plc (VRCI:LSE) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 9.25

0.00 (0.00)%

GBX 0.03B

0.13M

N/A

N/A

Icon

VRCI:LSE

Verici Dx Plc (GBX)
COMMON STOCK | LSE
GBX 9.25
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.03B

N/A

GBX 9.25

Verici Dx Plc (VRCI:LSE) Stock Forecast

N/A

Based on the Verici Dx Plc stock forecast from 0 analysts, the average analyst target price for Verici Dx Plc is not available over the next 12 months. Verici Dx Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Verici Dx Plc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Verici Dx Plc’s stock price was GBX 9.25. Verici Dx Plc’s stock price has changed by -5.13% over the past week, -19.57% over the past month and -36.21% over the last year.

No recent analyst target price found for Verici Dx Plc
No recent average analyst rating found for Verici Dx Plc

Company Overview Verici Dx Plc

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, incl...Read More

https://www.vericidx.com

Avon House, Penarth, United Kingdom, CF64 2EZ

14

December

GBX

UK

Adjusted Closing Price for Verici Dx Plc (VRCI:LSE)

Loading...

Unadjusted Closing Price for Verici Dx Plc (VRCI:LSE)

Loading...

Share Trading Volume for Verici Dx Plc Shares

Loading...

Compare Performance of Verici Dx Plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for VRCI:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Verici Dx Plc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDHC:LSE
Integrated Diagnostics Holding.. -0.01 (-2.83%) GBX0.18B 0.15 0.16

ETFs Containing VRCI

Symbol Name VRCI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Verici Dx Plc (VRCI:LSE) Stock

Stock Target Advisor's fundamental analysis for Verici Dx Plc's stock is Bearish.

Unfortunately we do not have enough data on VRCI:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on VRCI:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on VRCI:LSE's stock to indicate if its overvalued.

The last closing price of VRCI:LSE's stock was GBX 9.25.

The most recent market capitalization for VRCI:LSE is GBX 0.03B.

Unfortunately we do not have enough analyst data on VRCI:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Verici Dx Plc's stock.

As per our most recent records Verici Dx Plc has 14 Employees.

Verici Dx Plc's registered address is Avon House, Penarth, United Kingdom, CF64 2EZ. You can get more information about it from Verici Dx Plc's website at https://www.vericidx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...